StreetAlpha
Alzamend Neuro, Inc. · Earnings

ALZN Earnings Results and History

Latest: quarter ended Jul 31, 2026From SEC 8-K, 10-Q and 10-K filingsNext report: Dec 8, 2026

Alzamend Neuro, Inc.'s earnings at a glance: the latest results and outlook from the press release, revenue, margins and EPS for every quarter from the company's SEC filings, and how the stock moved after each report. New results show here within about a minute of being filed.

← ALZN stock page

Quarter ended Jul 31, 2026
From the 10-Q
  • Revenue–
  • Net income−$3M
  • EPS (GAAP)−$0.68

Filed Sep 10, 2026. The next earnings release shows here within a minute of filing.

EPS by quarter

GAAP diluted, 12 quarters
Oct 2023: EPS -$4.43-4.43Oct '23Jan 2024: EPS -$3.77-3.77Jan '24Apr 2024: EPS -$118.81-118.81Apr '24Jul 2024: EPS -$11.42-11.42Jul '24Oct 2024: EPS -$3.61-3.61Oct '24Jan 2025: EPS -$1.75-1.75Jan '25Apr 2025: EPS -$1.78-1.78Apr '25Jul 2025: EPS -$1.28-1.28Jul '25Oct 2025: EPS -$0.30-0.30Oct '25Jan 2026: EPS -$0.58-0.58Jan '26Apr 2026: EPS -$0.74-0.74Apr '26Jul 2026: EPS -$0.68-0.68Jul '26

Quarter by quarter

from 10-Q and 10-K filings
Quarter endedRevenueGrowthOp marginNet incomeEPS
Jul 2026–––−$3M−$0.68
Apr 2026–––−$2.9M−$0.74
Jan 2026–––−$2.2M−$0.58
Oct 2025–––−$1M−$0.30
Create a free account to see all 12 quarters, or sign in.

EPS here is GAAP diluted, as filed with the SEC. Estimates are usually based on adjusted EPS, so the two can differ. Growth compares with the same quarter a year earlier.

Year by year

fiscal years, from 10-K filings
Year endedRevenueGrowthOp marginNet incomeEPS
Apr 30, 2026–––−$8.8M−$2.63
Apr 30, 2025–––−$4.5M−$11.32
Apr 30, 2024–––−$9.9M−$132.33
Apr 30, 2023–––−$14.9M−$22.89
Apr 30, 2022–––−$12.4M−$0.14

Filings and dates

SEC EDGAR
  • Dec 8, 2026Next earnings reportexpected
  • Sep 10, 2026Quarterly report10-Q All filings

Also see ALZN institutional ownership and the earnings calendar.

ALZN earnings FAQ

When is ALZN's next earnings date?

Alzamend Neuro, Inc. is expected to report on Dec 8, 2026. Dates can move until the company confirms them.

Is ALZN's revenue growing?

In the quarter ended Jul 31, 2026 revenue was . The table on this page shows every quarter from the company's 10-Q and 10-K filings.

Where do these numbers come from?

Results, guidance and financials come from Alzamend Neuro, Inc.'s own SEC filings: the earnings press release (Form 8-K) and the quarterly and annual reports (10-Q and 10-K). Key takeaways summarize the press release. Estimates and price moves come from market data.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Results come from company filings with the SEC. Estimates are consensus figures from before each report. Key takeaways summarize the company's press release and may contain errors; the press release is the authoritative source.